FRANCHISE HERALD
Tuesday August 4, 2020

updated - August 4, 2020 Tuesday EDT

Johnson and Johnson Accepts Ortho-Clinical Diagnostics Business Offer From Caryle Group

Mar 31, 2014 01:02 PM EDT | By Justin Stock
Tags
Johnson and Johnson
Close
Johnson and Johnson Headquarters
Johnson and Johnson sold its ortho-clinical diagnostics entity to the Carlyle Group.(Photo : Creative Commons)

Johnson and Johnson's ortho-clinical diagnostics division now officially belongs to the Carlyle Group after the company consented to obtain it Monday for $4 billion a press release reported.

Carlyle made its proposal for the blood service entity in January, and was agreed to after several sessions with work councils, and trade unions. The next step in the process is the deal's closure, scheduled for 2014's halfway point.

"Ortho-Clinical Diagnostics is an established global brand with a reputation for quality and innovation. Through accelerated investment in research and product development and continued expansion into both emerging and established markets, we expect to tap into rising demand for sophisticated medical diagnostic products and services worldwide," Stephen Wise, managing director at the Carlyle Group said in a statement when the deal was first initiated in January.

According to The Wall Street Journal, the ortho-clinical diagnostics service has vitro diagnostic products which can sense diseases, conditions, and infection the United States Food and Drug Administration reported on their website. The examinations are also utilized in labs, and medical professional environments, along with at home.

The entity also includes donor screenings for transfusions or the process of transferring blood into a vein or artery according to the Merriam-Webster dictionary definition, and products that match a person's blood types.    

"We are excited to work with Carlyle and believe OCD will be well-positioned as an independent company focused exclusively on the in vitro diagnostics market. In combination with Carlyle's global reach and deep experience in the healthcare sector, OCD will have the opportunity to invest in new, innovative products and services for its customers and provide an environment for its professionals to excel in a competitive global marketplace," Eric Compton, world-wide president of Ortho-Clinical Diagnostics said in a statement.

Johnson and Johnson manufactures prescription drugs, medical devices, band aids, and listerine. 

Get the Most Popular Franchiseherald Stories in a Weekly Newsletter
© 2015 Franchise Herald. All rights reserved.

Connect With Franchise News

Email Newsletter

TOP 10 FRANCHISES OF 2020

  • RANK
    FRANCHISE NAME
    STARUP COSTS
  • 1nc
    Hampton Hotels
    $3.7M - 13.52M
  • 2nc
    Subway
    $85.2K - 260.35K
  • 3up
    Jiffy Lube Int'l. Inc.
    $196.5K - 304K
  • 4down
    7-Eleven Inc.
    $30.8K - 1.64M
  • 5up
    Supercuts
    $103.55K - 196.5K
  • 6up
    Anytime Fitness
    $56.3K - 353.9K
  • 7down
    Servpro
    $133.05K - 181.45K
  • 8down
    Denny's Inc.
    $1.18M - 2.4M
  • 9down
    McDonald's
    $1M - 2.16M
  • 10down
    Pizza Hut Inc.
    $295K - 2.15M
Real Time Analytics